Trial Profile
Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea Capsules Compared to Placebo After an Initial 12 Week Treatment Regimen With Oracea and MetroGel 1% in Adults With Rosacea
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Aug 2022
Price :
$35
*
At a glance
- Drugs Doxycycline (Primary) ; Metronidazole
- Indications Bacterial infections; Rosacea
- Focus Therapeutic Use
- Sponsors Galderma Research & Development
- 08 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 19 Jun 2013 Planned End Date changed from 1 Jan 2013 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 25 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.